Pharmaceuticals, Biotechnology and Life Sciences
Research includes a potential new drug for colorectal cancer, as well as new studies on geriatric oncology and supportive care medicine.
DOUGLAS, Isle of Man–(BUSINESS WIRE)–Juvenescence Limited, a life sciences company focused on therapies to modify aging and increasing healthy human…
Callers will speak directly to a certified licensed mental health clinician PHOENIX–(BUSINESS WIRE)–Magellan Health, Inc. (NASDAQ: MGLN), today announced that…
AstraZeneca on Friday reported several clinical results from its studies, including Imfinzi and Enhertu, with meaningful outcomes.
Sanofi said Friday that Libtayo (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time.
NEW YORK–(BUSINESS WIRE)–As announced today by the Austrian Breast & Colorectal Cancer Study Group and the Alliance Foundation Trials, LLC,…
NEW YORK–(BUSINESS WIRE)–As announced today by the Austrian Breast & Colorectal Cancer Study Group and the Alliance Foundation Trials, LLC,…
Mylan said on Friday that the U.S. Patent and Trademark Appeal Board (PTAB) has ruled in favor of Mylan in inter partes review (IPR) proceedings finding all challenged claims of Sanofi’s Lantus® SoloSTAR® device patents, U.S. Patent Nos. 8,603,044, 8,992,486, and 9,526,844 unpatentable.
CHICAGO–(BUSINESS WIRE)–Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use…
CHICAGO–(BUSINESS WIRE)–Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use…